Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiloride for lithium-associated polyuria
NL-OMON46002Withdrawn
- Sponsor
- Maasstad Ziekenhuis
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of amiloride in Nephrogenic Diabetes Insipidus (NDI) and diuresis, sponsored by Maasstad Ziekenhuis. Primary endpoint: Change in 24-hour urine volume. Planned start Apr 2017; status: withdrawn.
02
Drugs
amiloride
03
Conditions
Nephrogenic Diabetes Insipidus (NDI)diuresis
Beyond the preview
Go deeper on NL-OMON46002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46002.